T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
Clinical trials for T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA trials appear
Sign up with your email to follow new studies for T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Off-the-Shelf immune cell therapy tested for tough blood cancers
Disease control Recruiting nowThis study is testing a new type of cell therapy called WU-CART-007 for people with T-cell leukemia or lymphoma that has come back or hasn't responded to other treatments. The therapy uses donor immune cells engineered to attack cancer cells. The main goal is to see if it can put…
Matched conditions: T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE2 • Sponsor: Wugen, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New drug combo trial offers hope for aggressive blood cancer
Disease control Recruiting nowThis study is testing whether combining two drugs, venetoclax and azacitidine, is safe and effective as an initial treatment for adults with a fast-growing type of blood cancer called T-cell acute lymphoblastic leukemia (T-ALL). The trial will enroll 28 newly diagnosed patients t…
Matched conditions: T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE2 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New hope for Tough-to-Treat leukemia
Disease control Recruiting nowThis study is testing a drug called daratumumab-hyaluronidase for adults with T-cell acute lymphoblastic leukemia (T-ALL) who have a small amount of cancer cells left after chemotherapy. The goal is to see if this drug can eliminate these remaining cells and prevent the cancer fr…
Matched conditions: T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE2 • Sponsor: Eastern Cooperative Oncology Group • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New immune cell therapy targets aggressive blood cancers in kids and adults
Disease control Recruiting nowThis study is testing a new type of personalized immune cell therapy called CD7 CAR T-cells for patients with T-cell blood cancers that have returned or not responded to other treatments. The therapy involves collecting a patient's own immune cells or using donor cells, modifying…
Matched conditions: T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: Beijing GoBroad Hospital • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Engineered immune cells target tough blood cancers in early trial
Disease control Recruiting nowThis early-stage study is testing a new cell therapy for adults and children with T-cell leukemia or lymphoma that has come back after a stem cell transplant. Doctors take a patient's or their donor's immune cells, modify them in a lab to better target the cancer, and infuse them…
Matched conditions: T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New 'Living Drug' trial offers hope for patients with Hard-to-Treat leukemia
Disease control Recruiting nowThis is the first study in people testing a new type of CAR-T cell therapy called OC-1. It aims to see if this treatment is safe and can help control aggressive T-cell blood cancers (leukemia or lymphoma) that have come back or not responded to other treatments. The study will en…
Matched conditions: T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE1 • Sponsor: OneChain Immunotherapeutics • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
Scientists re-engineer Patients' own cells to fight aggressive blood cancers
Disease control Recruiting nowThis early-stage trial is testing a new personalized cell therapy for children and adults with T-cell leukemia or lymphoma that has come back or not responded to standard treatments. Doctors will collect a patient's own immune cells, modify them in a lab to better target the canc…
Matched conditions: T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE1 • Sponsor: University College, London • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
New hope for tough childhood cancers: trial tests aggressive drug combo
Disease control Recruiting nowThis study is testing whether a combination of three drugs—calaspargase pegol-mknl, decitabine, and venetoclax—can help control aggressive T-cell blood cancers that have returned or not responded to prior treatment in patients aged 1 month to 21 years. The main goals are to see i…
Matched conditions: T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 19, 2026 14:56 UTC
-
Scientists re-engineer Patient's own cells to hunt deadly blood cancers
Disease control Recruiting nowThis early-phase study is testing a new cell therapy for adults and children with aggressive T-cell leukemias or lymphomas that have returned or not responded to standard treatments. Doctors take a patient's own immune cells, genetically modify them in a lab to better recognize a…
Matched conditions: T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC
-
New hope for kids with tough blood cancers: trial tests adding powerful drugs
Disease control Recruiting nowThis study is testing whether adding one of two targeted drugs, dasatinib or venetoclax, to standard chemotherapy can help children and young adults with newly diagnosed T-cell leukemia or lymphoma. The goal is to see if these additions lead to better early results and improve su…
Matched conditions: T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE2 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated Mar 06, 2026 15:37 UTC